Edison Oncology Holding Corp. (EOHC)

Edison Oncology Holding was planning to go public, but the IPO was withdrawn on Feb 27, 2026.

IPO Price Range

$8.00 - $10.00

Shares Offered

2,827,777

Deal Size

$25.45M

Edison Oncology Holding Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	0.45	0.38	0.48
Revenue Growth	-	-21.73%	-
Gross Profit	0.45	0.38	0.48
Operating Income	-2.66	-1.99	-1.97
Net Income	-4.64	-1.17	-4.1

Fiscal Year	Current	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Investments	0.14	0.56	0.12
Total Debt	4.8	4.41	2.8
Net Cash (Debt)	-4.66	-3.84	-2.68
Net Cash Growth	-	-	-

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Cash Flow	-0.94	-1.1	-0.95
Free Cash Flow	-0.94	-1.1	-0.95
Free Cash Flow Growth	-	-	-

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Gross Margin	100.00%	100.00%	100.00%
Operating Margin	-596.65%	-528.62%	-409.31%
Pretax Margin	-971.96%	-231.49%	-865.23%
Profit Margin	-1039.44%	-311.31%	-851.35%
FCF Margin	-210.00%	-292.23%	-196.65%